Seigo Iwakawa
- Molecular Biology
- Pharmacology top 2%
- Oncology
- Pharmacology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Katsuhiko OkumuraFusao KomadaKumiko UedaMidori HiraiLeslie Z. BenetShota TanakaMasumi HasegawaKeiko Yagi
- Topics
- Pharmacy and Medical Practices (13 papers)Epigenetics and DNA Methylation (9 papers)Pharmacogenetics and Drug Metabolism (8 papers)
- Cited by
- PharmacologyPharmaceutical Science
- Journals
- Biochemical and Biophysical Research CommunicationsJournal of Controlled ReleaseInternational Journal of Pharmaceutics
- Partner nations
- JapanUnited StatesNew Zealand
In The Last Decade
Seigo Iwakawa
92 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 529
- Pharmacology 231
- Oncology 173
- Pharmacology 163
- Pulmonary and Respiratory Medicine 149
Countries citing papers authored by Seigo Iwakawa
This map shows the geographic impact of Seigo Iwakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seigo Iwakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seigo Iwakawa more than expected).
Fields of papers citing papers by Seigo Iwakawa
This network shows the impact of papers produced by Seigo Iwakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seigo Iwakawa. The network helps show where Seigo Iwakawa may publish in the future.
Co-authorship network of co-authors of Seigo Iwakawa
This figure shows the co-authorship network connecting the top 25 collaborators of Seigo Iwakawa. A scholar is included among the top collaborators of Seigo Iwakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seigo Iwakawa. Seigo Iwakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 4 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | Chitosan Induces Apoptosis via Caspase-3 Activation in Bladder Tumor Cells | 1 |
| 8 | 5 | |
| 9 | 121 | |
| 10 | 0 | |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 9 | |
| 15 | 2 | |
| 16 | 2 | |
| 17 | 5 | |
| 18 | 2 | |
| 19 | 19 | |
| 20 | 52 |
About Seigo Iwakawa
Seigo Iwakawa is a scholar working on Pharmacology, Geriatrics and Gerontology and Occupational Therapy, having authored 94 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacy and Medical Practices (13 papers), Epigenetics and DNA Methylation (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). The work is most often cited by research in Pharmacology (231 citations), Pharmaceutical Science (149 citations) and Pharmacology (163 citations). Seigo Iwakawa has collaborated with scholars based in Japan, United States and New Zealand. Frequent co-authors include Katsuhiko Okumura, Fusao Komada, Kumiko Ueda, Midori Hirai, Leslie Z. Benet, Shota Tanaka, Masumi Hasegawa, Keiko Yagi, Yusuke Tanigawara and E T Lin. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.